Gossamer Bio, Inc. (GOSS) Free cash flow 2018–2025
Gossamer Bio, Inc. (GOSS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$171.3MFY2025 · since FY2018: -$54.5M → -$171.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$171.3M | -4840.7% |
| FY2024 | -$3.5M | +97.8% |
| FY2023 | -$159.2M | +15.1% |
| FY2022 | -$187.4M | +1.6% |
| FY2021 | -$190.4M | -7.1% |
| FY2020 | -$177.9M | -20.3% |
| FY2019 | -$147.8M | -171.0% |
| FY2018 | -$54.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice